Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Datadog enters its November 6 earnings window with a curious split: the stock has rallied 27% over the past month to $271.34, yet short sellers have quietly been adding to their positions and options traders remain unusually calm about the whole thing.
Short interest has drifted upward through September and into October, rising 7.2% over the past month to reach 3.2% of the free float. That is a modest level in absolute terms, but the direction is worth noting: every week since late September has brought a small addition to the short book. The borrow market tells a reassuring story for longs, though. Cost to borrow has fallen sharply, down 27% on the week to just 0.27%, and availability is essentially unconstrained, with more than 330 million shares available to lend against roughly 10 million sold short. There is no squeeze pressure here, and no sign that the incremental short-selling is generating any urgency on the other side.
Options positioning is similarly undramatic. The put/call ratio has edged down to 0.82, fractionally below its 20-day average of 0.82 and miles from the 52-week defensive extreme of 1.01. The z-score is essentially flat at minus 0.14. For a stock that fell 17% the day after its last quarterly print in August, the absence of hedging demand is striking. Either the options market has already repriced that tail risk into the stock level, or participants expect a cleaner delivery this time.
The Street remains broadly constructive. With 32 buy ratings and a consensus target of $287, analysts see about 6% additional upside from here. Most of the post-August activity moved targets higher: Needham went to $300, Citigroup to $305, and Scotiabank to $285. UBS was the outlier, trimming its target to $280 from $315 while keeping a Buy rating, a reminder that at least one voice thinks the stock overshot the post-earnings recovery. The most recent action came from Wedbush in mid-September, initiating with an Outperform and a $275 target. The bull case rests on AI and cloud migration tailwinds, with revenue growth at 36% year-on-year, RPO of $3.47 billion, and net revenue retention holding in the low 120% range. Bears point to execution risk, competition, the dual-class share structure, and the dependence on existing customers expanding usage, a vulnerability highlighted by the August miss.
Valuation has expanded meaningfully on the rally. The P/E multiple has climbed roughly 20 points over the past 30 days to around 94 times trailing earnings, and EV/EBITDA has moved in the opposite direction, drifting down about 3 points to 69 times, as earnings estimates have grown faster than the enterprise value. The forward EPS growth factor ranks in the 85th percentile, and the analyst recommendation divergence score is near the top of the universe at the 94th percentile, reflecting how one-sided the buy-side consensus remains. The EV/EBIT factor, by contrast, scores at zero, the stock is priced for perfection on any normalised earnings basis.
On the ownership side, two co-founders appear in the top holders, both trimming. Alexis Le-Quoc, the CTO, sold roughly 33,000 shares in late September under a pre-arranged 10b5-1 plan, generating approximately $10.1 million in proceeds. CEO Olivier Pomel's position has also declined by around 197,000 shares per the most recent filing. Neither move is especially alarming given the plan-based nature, but the net 90-day insider figure is a net sale of $21.7 million, with no open-market buying to offset it. FMR (Fidelity) added nearly 6 million shares in the period to September 30, becoming the third-largest institutional holder at 5.2% of shares. BlackRock and State Street also added modestly.
Retail attention has faded relative to its own history: the Wikipedia-based attention score is running 1.4 standard deviations below the 90-day norm. That kind of quiet can precede either a dull tape or a sharp re-engagement around a catalyst. With the next earnings print 29 days away, the setup is less about where short interest or options positioning is today and more about whether the company can avoid a repeat of the August outcome, when a Q2 report that disappointed on guidance sent the stock down 17% in a single session.
See the live data behind this article on ORTEX.
Open DDOG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
